Novak at Novoste
This article was originally published in The Gray Sheet
Executive Summary
Alfred Novak becomes president, CEO and director of the brachytherapy device manufacturer Oct. 16, succeeding Bill Hawkins, who left in January to head Medtronic's vascular unit, Medtronic AVE (1"The Gray Sheet" Dec. 24, 2001, p. 7). Novak is chairman of Orbus Medical Technologies and Transurgical, and a founding member of Syntheon LLC. He has served as president and CEO of Biosense, sold to Johnson & Johnson in 1997, from 1996 and 1998, and as CFO of Cordis from 1989 until the company was bought by J&J in 1996...
You may also be interested in...
Novoste Looking For “Deal-Maker” As CEO Hawkins Moves To Medtronic
Novoste will shift focus from leveraging core technologies and building a sales infrastructure to diversification and growth following the departure of CEO and President Bill Hawkins in mid-January to head Medtronic's vascular unit, Medtronic AVE
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.